James Leckey Design recalls Firefly Splashy Bathseats with broken latches that could cause falls. Affected units have specific serial numbers or codes. Stop using immediately to prevent injury.
“James Leckey Design Firefly Splashy Bathseat Recall: Broken Latches Risk Falling.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/65823-james-leckey-design-firefly-splashy-bathseat-recall-broken-latches-risk. Based on FDA recall #Z-1683-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1683-2020%22&limit=1).
The FDA announced on Feb. 18, 2020, that James Leckey Design Ltd is recalling Firefly Floorsitter, Firefly Splashy Bathseat, and Firefly GoTo Seat products due to broken latches. The recall affects 1,241 units distributed nationwide.
Lot codes: LEC/178486 to LEC/206637; LEC/189092 to LEC/204087
Firefly Splashy codes beginning 176
Firefly GoTo Seat codes beginning 167 and including letter F in code
The hazard
The firm received reports of a number of broken latches on the floorsitter. The Splashy Bath-Seat is a portable bath seat for children aged 1-8, and the GoTo Seat is a light-weight, portable, postural support seat for kids aged between 1 and 8 with disabilities.
Context
GovInfoNow's records show James Leckey Design Ltd has 1 other recall on record since 2021-03-01: the MyWay Walker Chassis Recall regarding detached casters. Other recent recalls of similar products include Raz Design Mobile Shower Commode Chairs (2026-01-05).
How to tell if you have this one
Check the serial number on the seat. Affected units have LEC codes from 176000 to 206637 or 189092 to 204087. The Firefly Splashy-All series starts with code 176, and GoTo Seats have codes starting with 167 that include the letter F.
Brand
James Leckey Design
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Stop Using Immediately
The Splashy Bathseat has broken latches that could cause falls, so stop using it right away.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 36 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “US Nationwide distribution in the states of AL, AZ, AR, CA, CT, CO, FL, GA, SC, IA, HI, ID, IL, KS, KY, IN, MD, MA, LA, ME, MN, MI, MO, MT, NC, , NE, NH, ND, RI, TX, TN, VT, UT, WV, WA and WI.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, New Hampshire, North Carolina, North Dakota, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Washington, West Virginia, Wisconsin.
Recall timeline
FDA published this recall 57 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1683-2020 (February 18, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1683-2020 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.